ARCHIVES

Arimidex Gets Full Approval For HR+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991

Gene Vector Labs Seek Vector Producers

February 23, 1996

Community Cancer Center Group Formed to Deal With “Toad-Like Pace Of NCI,” Other Problems

June 7, 1974

ONF Invites Applications for Fatigue Research

April 19, 1996

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976

In Brief: Yale Names DeVita Center Director; Canellos, Anrman Lead ASCO; Bresnick To Head AACR

June 4, 1993